These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3338231)

  • 61. [Mushroom poisoning--the dark side of mycetism].
    Flammer R; Schenk-Jäger KM
    Ther Umsch; 2009 May; 66(5):357-64. PubMed ID: 19401986
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Acute renal failure after intake of mushrooms].
    Rojas Feria P; González Rodríguez JD; Canalejo González D; Sánchez Moreno A; Cabrera R; Martín Govantes J
    Nefrologia; 2008; 28(5):559-60. PubMed ID: 18816217
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users.
    McCambridge J; Winstock A; Hunt N; Mitcheson L
    Eur Addict Res; 2007; 13(1):57-64. PubMed ID: 17172780
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.
    Riley S; Thompson J; Griffin C
    Int J Drug Policy; 2010 Nov; 21(6):445-51. PubMed ID: 20810266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Psychedelic drugs.
    Kieffer SN; Moritz TB
    Pa Med; 1968 Apr; 71(4):57-67. PubMed ID: 4869313
    [No Abstract]   [Full Text] [Related]  

  • 66. Psychedelic drugs.
    Kieffer SN; Mortiz TB
    Pa Med; 1968 Apr; 71(4):57-67. PubMed ID: 4870533
    [No Abstract]   [Full Text] [Related]  

  • 67. [Narcotics abuse in adolescents].
    Leuner H
    Nervenarzt; 1971 Jun; 42(6):281-91. PubMed ID: 4931883
    [No Abstract]   [Full Text] [Related]  

  • 68. Some aspects of the current drug scene with emphasis on drugs in use by adolescents.
    Louria DB
    Pediatrics; 1968 Dec; 42(6):904-11. PubMed ID: 5726384
    [No Abstract]   [Full Text] [Related]  

  • 69. Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use.
    Roberts CA; Osborne-Miller I; Cole J; Gage SH; Christiansen P
    J Psychopharmacol; 2020 Sep; 34(9):999-1007. PubMed ID: 32674668
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Persistent symptoms after intake of hallucinogenic mushrooms].
    Kristensen LH; Sørensen BH
    Ugeskr Laeger; 1988 May; 150(20):1224-5. PubMed ID: 3376295
    [No Abstract]   [Full Text] [Related]  

  • 71. Availability of websites offering to sell psilocybin spores and psilocybin.
    Lott JP; Marlowe DB; Forman RF
    J Psychoactive Drugs; 2009 Sep; 41(3):305-7. PubMed ID: 19999684
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The content of Psilocybin in Norwegian Psilocybe semilanceata.
    Christiansen AL; Rasmussen KE; Høiland K
    Planta Med; 1981 Jul; 42(7):229-35. PubMed ID: 17401967
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serious mushroom poisonings in California requiring hospital admission, 1990 through 1994.
    Jacobs J; Von Behren J; Kreutzer R
    West J Med; 1996 Nov; 165(5):283-8. PubMed ID: 8993198
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Hallucinogenic fungi.
    Peden NR; Pringle SD
    Lancet; 1982 Feb; 1(8268):396-7. PubMed ID: 6120373
    [No Abstract]   [Full Text] [Related]  

  • 76. [The toxicological aspects of poisonings by psilocybine-containing mushrooms].
    Babakhanian RV; Bushuev ES; Kazankov SP; Kostyrko TA
    Sud Med Ekspert; 1997; 40(3):20-2. PubMed ID: 9304247
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Microscopic study of powders of hallucinogenic mushrooms--Psilocybe sp].
    Schäfer AT
    Arch Kriminol; 2000; 205(1-2):30-6. PubMed ID: 10726173
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Determination of psilocybin in hallucinogenic mushrooms by reversed-phase liquid chromatography with fluorescence detection.
    Saito K; Toyo'oka T; Kato M; Fukushima T; Shirota O; Goda Y
    Talanta; 2005 Apr; 66(3):562-8. PubMed ID: 18970021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [The impact of psilocybin on visual perception and spatial orientation--neuropsychological approach].
    Jastrzebski M; Bala A
    Psychiatr Pol; 2013; 47(6):1157-67. PubMed ID: 25007546
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Student's use of illicit drugs: a survey in a preventive health service].
    Morvan Y; Rouvier J; Olié JP; Lôo H; Krebs MO
    Encephale; 2009 Dec; 35 Suppl 6():S202-8. PubMed ID: 20141772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.